Skip to main content
. 2021 Oct 29;35(4):337–346. doi: 10.1093/ajh/hpab171

Table 2.

Effects of interventions on mean blood pressure across the whole trial, N = 975 participants (13,925 study visits for systolic blood pressure and 12,924 visits for diastolic blood pressure)

Change in systolic blood pressure, mm Hg Change in diastolic blood pressure, mm Hg
β (95% CI) P β (95% CI) P
All groups
 Usual care Reference Reference
 Weight loss −2.46 (−4.55, −0.37) 0.021 −0.98 (−2.50, 0.54) 0.21
 Sodium reduction −1.79 (−3.44, −0.14) 0.034 −0.50 (−1.50, 0.50) 0.33
 Weight loss and sodium reduction −4.33 (−6.48, −2.17) <0.001 −2.47 (−3.88, −1.06) 0.001
Factorial design—weight loss
 No weight lossa Reference Reference
 Weight loss −2.49 (−4.00, −0.98) 0.001 −1.48 (−2.51, −0.44) 0.005
Factorial design—sodium reduction
 No sodium reductiona Reference Reference
 Sodium reduction −1.81 (−3.20, −0.42) 0.011 −0.79 (−1.68, 0.09) 0.08

Change in follow-up blood pressure was modeled using a generalized estimating equation adjusted for baseline obesity status, field center, and baseline systolic or diastolic blood pressure. Interaction terms between weight loss and sodium reduction were nonsignificant. Abbreviation: CI, confidence interval.

aNo weight loss includes usual care and sodium reduction. No sodium reduction includes usual care and weight loss.